Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by Thomas H. Brix in
Google Scholar
PubMed
Search for other papers by Wolfgang Schima in
Google Scholar
PubMed
Search for other papers by Georg Zettinig in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Introduction During the past decades, the number of radiological examinations, particularly computed tomography (CT) and vascular interventional procedures, which require iodine-based contrast media (ICM) has risen dramatically [ 1 ]. Thus
Search for other papers by Katarzyna Pelewicz in
Google Scholar
PubMed
Search for other papers by Rafał Wolny in
Google Scholar
PubMed
Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by Piotr Miśkiewicz in
Google Scholar
PubMed
Introduction The proper synthesis of thyroid hormones is dependent on adequate iodine supply. The mean daily iodine intake recommended by the World Health Organization is 150 μg [ 1 ]. Iodinated contrast media (ICM) typically contain 13,500 μg
Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Agnieszka Piekiełko-Witkowska in
Google Scholar
PubMed
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Search for other papers by Corin Badiu in
Google Scholar
PubMed
Search for other papers by Josef Köhrle in
Google Scholar
PubMed
Search for other papers by Leonidas Duntas in
Google Scholar
PubMed
Levothyroxine, Liothyronine; Synthetic iodinated contrast media (e.g. iopanoic acid); Iodinated antiarrhythmic drug amiodarone Iodine-containing complexes, ‘iodophores’ Polymeric structures forming non-covalently boundcomplexes with iodine containing
Department of Endocrinology and Nephrology, Division of Nephrology, University Clinic Leipzig, Leipzig, Germany
Search for other papers by Luisa Paschke in
Google Scholar
PubMed
Search for other papers by Thomas Lincke in
Google Scholar
PubMed
Search for other papers by Katja Sibylle Mühlberg in
Google Scholar
PubMed
Search for other papers by Wolfram J. Jabs in
Google Scholar
PubMed
Search for other papers by Tom H. Lindner in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
cofactor for the renal damage. However, diagnosis of contrast-induced nephropathy requires an absolute increase in serum creatinine by ≥26.5 µmol/L from baseline within 48 h after contrast media application, or a relative increase in serum creatinine levels
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Nicola Viola in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
. 1 ), associated with negative thyroperoxidase autoantibodies (TPOAb), negative thyroglobulin autoantibodies (TgAb), and unremarkable thyroid ultrasound. In the 3 months prior to referral, no administration of iodinated contrast media was reported. At
Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Nunzia Tacelli in
Google Scholar
PubMed
Search for other papers by Lucia Russo in
Google Scholar
PubMed
Search for other papers by Laetitia Lebrun in
Google Scholar
PubMed
Search for other papers by Isabelle Salmon in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
solid areas. The other exclusion criteria were pregnancy or lactation, active malignancy, uncontrolled concomitant disease requiring further clinical investigation, previous radioiodine therapy, recent administration of iodine-contrast media, current
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Fernando Schmitt in
Google Scholar
PubMed
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Tamas Solymosi in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
clinical suspicion of substernal extension. If using contrast media, the risk of thyrotoxicosis should be considered. The aim is to assess the extension into the upper mediastinum, the location and dimensions of the trachea, and the anatomical relation of